Why Private Wegovy vs Mounjaro Dosage Matters in 2025
Private Prescription Wegovy vs Mounjaro Dosage: Avoiding NHS Barriers
The NHS route for accessing either Wegovy or Mounjaro typically requires GP referral to specialist weight management services, followed by strict eligibility criteria and waiting lists often exceeding 6 months. Private prescription eliminates these barriers entirely, allowing direct access to both treatments through clinical assessment. Wegovy follows a 5-step dose escalation (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) over 16 weeks, whilst Mounjaro uses 4 escalation steps (2.5mg, 5mg, 7.5mg, 10mg or 15mg) over 12 weeks to maintenance.
The wegovy vs mounjaro dosage comparison becomes particularly relevant for private patients because you're paying directly for each pen, making the escalation schedule and maintenance costs crucial factors. EverydayMeds provides both options with transparent pricing, allowing you to make informed decisions based on your budget, lifestyle preferences, and clinical suitability rather than NHS availability constraints.
Wegovy vs Mounjaro Dosage Pricing: Complete UK Cost Breakdown
Understanding the true cost difference between Wegovy vs Mounjaro dosage schedules helps inform your private prescription choice. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose using discount codes FIRST40 (new customers) or DOSE25 (returning customers) applied at checkout. Our Getting Started bundles provide convenient dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, eliminating multiple orders during your initial treatment phase.
Mounjaro follows a different pricing structure due to its alternative dosing schedule, with costs varying based on whether you progress to the 10mg or 15mg maintenance dose. Both treatments represent prescription-only medicines requiring clinical assessment, but the wegovy vs mounjaro dosage comparison often favours Wegovy for predictable monthly costs once you reach the 2.4mg maintenance dose, providing budget certainty for long-term weight management commitment.
Clinical Evidence: Wegovy vs Mounjaro Dosage Effectiveness
The STEP trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the primary STEP 1 trial, as reported by Wilding et al., NEJM, 2021. Wegovy's dose escalation to 2.4mg weekly represents the therapeutically optimal dose established through clinical research, balancing efficacy with tolerability across the 16-week escalation period.
Mounjaro's SURMOUNT trials showed different results using the tirzepatide dual GIP/GLP-1 mechanism, though direct wegovy vs mounjaro dosage comparisons cannot be made due to different trial populations, endpoints, and methodologies. Both treatments may help support weight management when used alongside a reduced-calorie diet and increased physical activity, with your prescriber able to guide selection based on individual clinical factors rather than comparative trial percentages.
How Wegovy Works: GLP-1 Mechanism and Dosage Impact
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines after eating. The medication works by reducing appetite, promoting feelings of fullness after smaller meals, and may help reduce food cravings by acting on brain appetite centres. The gradual dose escalation from 0.25mg to 2.4mg over 16 weeks allows your body to adapt to these metabolic changes whilst minimising potential side effects like nausea or digestive discomfort. Each weekly injection using the FlexTouch pen delivers consistent medication levels, supporting sustained appetite regulation throughout your treatment journey. The 2.4mg maintenance dose represents the therapeutically established level for optimal weight management support, distinguishing Wegovy from lower-dose formulations like Ozempic, which is licensed specifically for type 2 diabetes treatment.
Private Prescription Ordering: 3-Minute Assessment to Next-Day Delivery
EverydayMeds streamlines the wegovy vs mounjaro dosage decision through our clinical assessment process, taking approximately 3 minutes to complete online without GP referral requirements. Your responses undergo review by qualified prescribers within 3 working days (or 24 hours with express service), who evaluate suitability for either treatment based on BMI, medical history, and weight management goals. Once approved, your chosen medication ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements crucial for both Wegovy and Mounjaro stability. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine Novo Nordisk Wegovy or authentic Eli Lilly Mounjaro, identical to NHS-dispensed medications but without the waiting lists or referral barriers. The entire process from assessment completion to receiving your first dose typically takes 4-5 days, dramatically faster than NHS specialist weight management referrals.
Storage Advantage: Wegovy vs Mounjaro Dosage Practicality
A crucial practical difference in the wegovy vs mounjaro dosage comparison lies in storage requirements once removed from refrigeration. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks after first removal from the fridge, whilst Mounjaro maintains stability for 21 days at room temperature. This storage advantage makes Wegovy more suitable for frequent travellers, business trips, or households with limited refrigerator space, as the extended room temperature stability reduces storage anxiety. Both medications arrive in temperature-controlled packaging and should be stored in the fridge (2-8°C) until first use, but Wegovy's superior ambient stability provides greater flexibility for your weekly injection schedule. The FlexTouch pen design used for Wegovy also offers ergonomic advantages, though both medications use pre-filled pens designed for self-administration.
NHS vs Private: Why Wegovy vs Mounjaro Dosage Choice Matters More Privately
NHS weight management services typically pre-determine whether you receive Wegovy or Mounjaro based on local formulary decisions, clinical commissioning group policies, and specialist service preferences rather than individual patient choice. Private prescription reverses this dynamic, allowing you to actively participate in the wegovy vs mounjaro dosage decision based on your lifestyle, budget, and treatment preferences. Cost transparency becomes crucial since you're funding treatment directly, making factors like maintenance dose pricing, escalation schedule length, and storage practicality personally relevant rather than system-determined.
The ability to switch between treatments if your initial choice proves unsuitable also differs significantly between NHS and private routes. Private patients can transition between Wegovy and Mounjaro with prescriber guidance and clinical assessment, whilst NHS patients often face additional referral delays and formulary restrictions that may limit treatment flexibility.
Start Your Private Wegovy vs Mounjaro Assessment Today
Both Wegovy and Mounjaro are available through EverydayMeds with transparent pricing, expert prescriber guidance, and next-day delivery once approved. New customers can use code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 to access our competitive pricing structure. Our clinical team helps determine which treatment aligns with your weight management goals, lifestyle requirements, and budget considerations through personalised assessment rather than generic treatment allocation. Complete your 3-minute assessment at https://everydaymeds.co.uk/collections/wegovy to begin comparing these prescription-only medicines with qualified medical guidance. The wegovy vs mounjaro dosage decision becomes clearer when you have access to both options without NHS waiting lists, GP referrals, or specialist service constraints.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
